Pneumocystis Jirovecii Infection in Autologous Hematopoietic Stem Cell Transplant Recipients

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2022 Dec 22

PMID 36550198

Authors

John Coda

Kadee Raser

Sarah M Anand

Monalisa Ghosh

Kevin Gregg

Jinju Li

John J Maciejewski

Attaphol Pawarode

Mary M Riwes

Christina Tillman

Avery Polk

Malathi Kandarpa

Moshe Talpaz

Sung Won Choi

Gregory A Yanik

John M Magenau

Matthew J Pianko

Affiliations

Soon will be listed here.

References

Meyers J, Pifer L, Sale G, Thomas E . The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis. 1979; 120(6):1283-7. DOI: 10.1164/arrd.1979.120.6.1283. View

Meyers J, Flournoy N, Thomas E . Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis. 1982; 4(6):1119-32. DOI: 10.1093/clinids/4.6.1119. View

Rodriguez M, Fishman J . Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004; 17(4):770-82, table of contents. PMC: 523555. DOI: 10.1128/CMR.17.4.770-782.2004. View

Roblot F, Godet C, Le Moal G, Garo B, Souala M, Dary M . Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2002; 21(7):523-31. DOI: 10.1007/s10096-002-0758-5. View

Williams K, Ahn K, Chen M, Aljurf M, Agwu A, Chen A . The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Bone Marrow Transplant. 2016; 51(4):573-80. PMC: 4823157. DOI: 10.1038/bmt.2015.316. View

Evernden C, Dowhan M, Dabas R, Chaudhry A, Kalra A, Dharmani-Khan P . High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. Cytotherapy. 2020; 22(1):27-34. DOI: 10.1016/j.jcyt.2019.11.002. View

Rahman S, Rybicki L, Hamilton B, Pohlman B, Jagadeesh D, Cober E . Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma. Transpl Infect Dis. 2019; 21(4):e13114. DOI: 10.1111/tid.13114. View

Dykewicz C . Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis. 2001; 33(2):139-44. DOI: 10.1086/321805. View

Hanauer D, Mei Q, Law J, Khanna R, Zheng K . Supporting information retrieval from electronic health records: A report of University of Michigan's nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). J Biomed Inform. 2015; 55:290-300. PMC: 4527540. DOI: 10.1016/j.jbi.2015.05.003. View

10.

Wishart D, Feunang Y, Guo A, Lo E, Marcu A, Grant J . DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017; 46(D1):D1074-D1082. PMC: 5753335. DOI: 10.1093/nar/gkx1037. View

11.

Reid A, Chen S, Worth L . Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis. 2011; 24(6):534-44. DOI: 10.1097/QCO.0b013e32834cac17. View

12.

Sepkowitz K . Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis. 1993; 17 Suppl 2:S416-22. DOI: 10.1093/clinids/17.supplement_2.s416. View

13.

Yale S, Limper A . Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996; 71(1):5-13. DOI: 10.4065/71.1.5. View

14.

Worth L, Dooley M, Seymour J, Mileshkin L, Slavin M, Thursky K . An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer. 2005; 92(5):867-72. PMC: 2361905. DOI: 10.1038/sj.bjc.6602412. View

15.

Roux A, Gonzalez F, Roux M, Mehrad M, Menotti J, Zahar J . Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients. Med Mal Infect. 2014; 44(5):185-98. DOI: 10.1016/j.medmal.2014.01.007. View

16.

Jiang X, Mei X, Feng D, Wang X . Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis. PLoS One. 2015; 10(4):e0122171. PMC: 4409297. DOI: 10.1371/journal.pone.0122171. View

17.

Martin-Garrido I, Carmona E, Specks U, Limper A . Pneumocystis pneumonia in patients treated with rituximab. Chest. 2012; 144(1):258-265. PMC: 4694106. DOI: 10.1378/chest.12-0477. View

18.

Hardy A, Wajszczuk C, Suffredini A, Hakala T, Ho M . Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis. 1984; 149(2):143-7. DOI: 10.1093/infdis/149.2.143. View

19.

Ferreira A, Ramos J, Fatobene G, Rocha V . Pneumonia during Brentuximab Vedotin Therapy: A Case Report and Literature Review. Case Rep Hematol. 2019; 2019:8982937. PMC: 6458937. DOI: 10.1155/2019/8982937. View

20.

Marchesini G, Nadali G, Facchinelli D, Candoni A, Cattaneo C, Cuccaro A . Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study. Leuk Lymphoma. 2020; 61(12):3002-3005. DOI: 10.1080/10428194.2020.1786562. View